Local Institution
Lisbon 1769-001
0 studies enrolling now · 15 studies all time
What they study most
AIDS, Acute Coronary Syndromes, Bipolar Disorder, Breast Cancer, Cancer, Cancer of the Stomach, Chronic Hepatitis B, Congestive Heart Failure, Gastric Cancer, Gastroesophageal Junction, HIV, HIV Infections
Studies at this site
- Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer — Completed
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
- Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
- An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling
- Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — Completed
- Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access — Completed
- BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis — Completed
- Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) — Completed
- Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
- Study of Aripiprazole in Patients With Bipolar I Disorder — Completed
- BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
- Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) — Completed